Navigation Links
MolecularHealth demonstrates Personalized Cancer Therapy Solutions at 2013 CeBIT
Date:3/5/2013

NEW YORK and HEIDELBERG, Germany, March 5, 2013 /PRNewswire/ --  MolecularHealth, a leader in clinico-molecular informatics™, today announced that the company will demonstrate their latest capabilities at CeBIT 2013, taking place in Hannover, Germany March 5-9. The company is advancing precision medicine by providing decision support solutions that translate patient-specific molecular and genomic data, treatment-relevant clinical history, and published scientific evidence in combination with mechanism-based therapy knowledge into safer, more effective drug choices. MolecularHealth's Personalized Cancer Therapy Solutions offer health providers and patients an integrated service that unlocks evidence-based treatment strategies from the genome, patient clinical history and extensive knowledge about drug therapy mechanisms of action.

(Logo: http://photos.prnewswire.com/prnh/20130305/DA68911LOGO)

Benefitting from the unprecedented speed and performance of the SAP HANA® platform, the offering aims to tackle the challenges of immense bodies of disparate medical, biological and drug data, manual and time consuming analysis, and the increasingly complex treatment paradigms affecting pathologists, oncologists and patients and their families. MolecularHealth will demonstrate its Molecular Analysis of Side Effects™ (MASE) and Oncology Decision Support capabilities in the SAP booth, Hall 4 Stand C04. These capabilities reflect SAP's recent entry with the SAP HANA platform and partners such as MolecularHealth into the increasingly accessible field of genomics and next generation sequencing-driven clinical decision support.

About MolecularHealth

MolecularHealth, a clinico-molecular informatics company offering mechanism-based drug safety and Personalized Cancer Therapy Solutions, is advancing precision medicine by translating patient-specific molecular and genomic data, clinical history, drug knowledge and published scientific and medical evidence into safer, more effective drug choices for patients. The company's solutions range from a next generation drug safety assessment and prediction tool that analyzes the molecular basis of adverse events to a treatment decision support offering that informs evidence-based treatment strategies for cancer patients.  MolecularHealth's collaborators include the University of Texas MD Anderson Cancer Center, SAP AG, and the U.S. Food and Drug Administration (FDA). Visit www.molecularhealth.com.

© 2013 The MolecularHealth name and logo are trademarks of Molecular Health AG.

SAP, SAP HANA, and all SAP logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries.
All other product and service names mentioned are the trademarks of their respective companies.


'/>"/>
SOURCE MolecularHealth
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
4. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
5. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
6. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
7. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
8. Philips demonstrates innovations in nuclear medicine imaging with a comprehensive portfolio of NM applications for IntelliSpace Portal
9. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
10. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
11. LIVE VIA SATELLITE: Physician Demonstrates New Medical Technology to Combat Back Pain without Major Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
Breaking Medicine News(10 mins):